BTF acquired by bioMerieux
Australian company BTF Decisive Microbiology has been acquired by bioMerieux. French clinical diagnostics company bioMérieux is present in more than 150 countries through 35 subsidiaries and has a large network of distributors.
The new acquisition will make BTF's products more accessible to a wider distribution network.
Initially, BTF will operate as a standalone subsidiary, so all existing customers will not see any changes in the short term. BTF's contact details remain unchanged.
Australia–Vietnam collaborative research projects — applications open
Until 20 July, grant applications for projects in recycling and waste management, a sustainable...
AI and deep-tech research program receives $400K grant
A program designed to help scientists transform AI and deep-tech research into commercially...
Horizon Europe negotiations conclude
Once associated, Australian researchers and entities will be able to access Horizon Europe...
